Cargando…

Internal cardioversion of persistent atrial fibrillation in implantable cardioverter defibrillator patients: the juice is not worth the squeeze

Detalles Bibliográficos
Autores principales:	Berger, W. R., Knops, R. E., de Groot, J. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2013
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833918/ https://www.ncbi.nlm.nih.gov/pubmed/24155104 http://dx.doi.org/10.1007/s12471-013-0486-8

Ejemplares similares

Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator
por: Limantoro, I., et al.
Publicado: (2013)

Safety of COVID-19 booster dose: is the juice worth the squeeze?
por: Madhi, Shabir A, et al.
Publicado: (2023)

Who benefits from implantable cardioverter defibrillator therapy, and who pays the price?
por: Olde Nordkamp, L. R. A., et al.
Publicado: (2013)

Evolving use and indications for implantable cardioverter defibrillators
por: de Groot, J. R.
Publicado: (2018)

Do elderly patients benefit from implantable-cardioverter defibrillators?
por: de Groot, J. R.
Publicado: (2014)

Implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy: a need or not?
por: de Groot, Joris R.
Publicado: (2023)

Commentary: Is the juice worth the squeeze?
por: Demmy, Todd L.
Publicado: (2020)

Commentary: Is the juice worth the squeeze?
por: Lantz, Gurion, et al.
Publicado: (2021)

Programmed inappropriate ICD ventricular defibrillation for cardioversion of persistent atrial fibrillation
por: Korantzopoulos, Panagiotis, et al.
Publicado: (2008)

Do we understand the rationale behind driving restrictions in patients with an implantable cardioverter defibrillator?
por: Baalman, S. W. E., et al.
Publicado: (2018)

Antimicrobial catheters in the ICU: is the juice worth the squeeze?
por: Safdar, Nasia
Publicado: (2009)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

Pseudonymization for research data collection: is the juice worth the squeeze?
por: Kohlmayer, Florian, et al.
Publicado: (2019)

Advanced imaging in surveillance of Barrett’s esophagus: Is the juice worth the squeeze?
por: Cerrone, Sara A, et al.
Publicado: (2019)

The Juice is Worth the Squeeze: Psychiatry Residents’ Experience of Balint Group
por: Nalan, Prathiksha, et al.
Publicado: (2022)

Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
por: van der Stuijt, W., et al.
Publicado: (2020)

Diagnostic tests to predict outcome in patients with implantable cardioverter defibrillators: it is not that simple!
por: Maass, A. H.
Publicado: (2014)

QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation
por: Younis, Arwa, et al.
Publicado: (2022)

Dual‐chamber implantable cardioverter–defibrillator. Is it useful in patient with permanent atrial fibrillation?
por: Porres‐Aracama, José M., et al.
Publicado: (2016)

Defining the benefit: Cardioversion of persistent atrial fibrillation
por: Nedios, Sotirios, et al.
Publicado: (2021)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Long‐term follow‐up of the two‐incision implantation technique for the subcutaneous implantable cardioverter‐defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020)

Implantable Cardioverter-Defibrillator Implantation in a Patient with Atrial Standstill
por: Park, So Ra, et al.
Publicado: (2009)

Defibrillation threshold of internal cardioversion prior to ablation predicts atrial fibrillation recurrence
por: Sawasaki, Kohei, et al.
Publicado: (2021)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Silent atrial fibrillation in patients with an implantable cardioverter defibrillator and coronary artery disease (INDICO AF) trial: study rationale and design
por: Baalman, S. W. E., et al.
Publicado: (2018)

Diagnosis of atrial fibrillation in heart failure patients with implantable cardioverter defibrillator or cardiac resynchronisation therapy
por: Dominik, Barbara, et al.
Publicado: (2021)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Atrial pacing–induced oversensing in subcutaneous implantable cardioverter-defibrillator
por: Wharmby, Amy, et al.
Publicado: (2023)

Modulation of α-synuclein expression in transgenic animals for modelling synucleinopathies — is the juice worth the squeeze?
por: Buchman, Vladimir L., et al.
Publicado: (2008)

Patient education interventions for optimizing bowel cleansing before colonoscopy: is the juice worth the squeeze?
por: Mohammed, Noor, et al.
Publicado: (2015)

Validity of device-measured activity in patients with an implantable cardioverter-defibrillator
por: Kolk, M Z H, et al.
Publicado: (2023)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement
por: de Veld, Jolien A, et al.
Publicado: (2023)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

A Cardioversion and Renal Dysfunction Cascade: Cardioversion for Atrial Fibrillation, Acute Kidney Injury, and Recurrence of Atrial Fibrillation
por: Asemota, Iriagbonse R, et al.
Publicado: (2020)

Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator
por: Karnik, Ankur A., et al.
Publicado: (2017)

Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit
por: Kolk, Maarten Z H, et al.
Publicado: (2023)

Cardiac Magnetic Resonance Imaging–Derived Left Atrial Characteristics in Relation to Atrial Fibrillation Detection in Patients With an Implantable Cardioverter‐Defibrillator
por: Hopman, Luuk H. G. A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e4egjuaqledu2k1mo3th57nuge